Tricuspid Regurgitation
111
36
49
28
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.8%
2 terminated out of 111 trials
93.3%
+6.8% vs benchmark
5%
5 trials in Phase 3/4
18%
5 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 28 completed trials
Clinical Trials (111)
TTVR Early Feasibility Study
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Laplace Early Feasibility Study - Canada
Edwards CLASP TR EFS
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
Comparing the Effects of Newer Pacemakers and Their Effects on the Heart and Valve Function in the Short-term.
Evaluation of a Management Algorithm for TAVI Patients With Concomitant Mitral or Tricuspid Regurgitation
EFS of the DUO System for Tricuspid Regurgitation
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System
TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System
Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment
Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease
Clinical Study of Edwards Cardioband FIT Valve Repair System
Band Versus Ring for Tricuspid Regurgitation
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
Berlin Registry of Right Heart Interventions